INS and type 2 diabetes mellitus: Finally, we briefly summarise results from encouraging clinical trials about the potential of anticytokine therapies in T2D, discussing the effects of these drugs on systemic and islet inflammation, beta-cell function, insulin secretion, and insulin sensitivity.